Menu
GWAS Study

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.

Jansen IE, van der Lee SJ, Gomez-Fonseca D et al.

36066633 PubMed ID
GWAS Study Type
13116 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JI
Jansen IE
VD
van der Lee SJ
GD
Gomez-Fonseca D
DR
de Rojas I
DM
Dalmasso MC
GB
Grenier-Boley B
ZA
Zettergren A
MA
Mishra A
AM
Ali M
AV
Andrade V
BC
Bellenguez C
KL
Kleineidam L
KF
Küçükali F
SY
Sung YJ
TN
Tesí N
VE
Vromen EM
WD
Wightman DP
AD
Alcolea D
AM
Alegret M
AI
Alvarez I
AP
Amouyel P
AL
Athanasiu L
BS
Bahrami S
BH
Bailly H
BO
Belbin O
BS
Bergh S
BL
Bertram L
BG
Biessels GJ
BK
Blennow K
BR
Blesa R
BM
Boada M
BA
Boland A
BK
Buerger K
Carracedo Á
CL
Cervera-Carles L
CG
Chene G
CJ
Claassen JAHR
DS
Debette S
DJ
Deleuze JF
DD
de Deyn PP
DJ
Diehl-Schmid J
DS
Djurovic S
DO
Dols-Icardo O
DC
Dufouil C
DE
Duron E
DE
Düzel E
FT
Fladby T
FJ
Fortea J
FL
Frölich L
GP
García-González P
GM
Garcia-Martinez M
GI
Giegling I
GO
Goldhardt O
GJ
Gobom J
GT
Grimmer T
HA
Haapasalo A
HH
Hampel H
HO
Hanon O
HL
Hausner L
HS
Heilmann-Heimbach S
HS
Helisalmi S
HM
Heneka MT
HI
Hernández I
HS
Herukka SK
HH
Holstege H
JJ
Jarholm J
KS
Kern S
KA
Knapskog AB
KA
Koivisto AM
KJ
Kornhuber J
KT
Kuulasmaa T
LC
Lage C
LC
Laske C
LV
Leinonen V
LP
Lewczuk P
LA
Lleó A
DM
de Munain AL
LS
Lopez-Garcia S
MW
Maier W
MM
Marquié M
MM
Mol MO
ML
Montrreal L
MF
Moreno F
MS
Moreno-Grau S
NG
Nicolas G
NM
Nöthen MM
OA
Orellana A
PL
Pålhaugen L
PJ
Papma JM
PF
Pasquier F
PR
Perneczky R
PO
Peters O
PY
Pijnenburg YAL
PJ
Popp J
PD
Posthuma D
PA
Pozueta A
PJ
Priller J
PR
Puerta R
QI
Quintela I
RI
Ramakers I
RE
Rodriguez-Rodriguez E
RD
Rujescu D
SI
Saltvedt I
SP
Sanchez-Juan P
SP
Scheltens P
SN
Scherbaum N
SM
Schmid M
SA
Schneider A
SG
Selbæk G
SP
Selnes P
SA
Shadrin A
SI
Skoog I
SH
Soininen H
TL
Tárraga L
TS
Teipel S
TB
Tijms B
TM
Tsolaki M
VB
Van Broeckhoven C
VD
Van Dongen J
VS
van Swieten JC
VR
Vandenberghe R
VJ
Vidal JS
VP
Visser PJ
VJ
Vogelgsang J
WM
Waern M
WM
Wagner M
WJ
Wiltfang J
WM
Wittens MMJ
ZH
Zetterberg H
ZM
Zulaica M
VD
van Duijn CM
BM
Bjerke M
ES
Engelborghs S
JF
Jessen F
TC
Teunissen CE
PP
Pastor P
HM
Hiltunen M
IM
Ingelsson M
AO
Andreassen OA
CJ
Clarimón J
SK
Sleegers K
RA
Ruiz A
RA
Ramirez A
CC
Cruchaga C
LJ
Lambert JC
VD
van der Flier W
Chapter II

Abstract

Summary of the research findings

Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer's disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n = 8074; replication n = 5042 individuals). Besides the APOE locus, novel associations with two other well-established AD risk loci were observed; CR1 was shown a locus for Aβ42 and BIN1 for pTau. GMNC and C16orf95 were further identified as loci for pTau, of which the latter is novel. Clustering methods exploring the influence of all known AD risk loci on the CSF protein levels, revealed 4 biological categories suggesting multiple Aβ42 and pTau related biological pathways involved in the etiology of AD. In functional follow-up analyses, GMNC and C16orf95 both associated with lateral ventricular volume, implying an overlap in genetic etiology for tau levels and brain ventricular volume.

8,074 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

13116
Total Participants
GWAS
Study Type
Yes
Replicated
5,042 individuals
Replication Participants
European
Ancestry
Netherlands, Sweden, U.S., Belgium, Finland, France, Germany, Spain, Norway
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.